ArticleFrontiers in immunology2025

A novel tertiary lymphoid structure-associated signature accurately predicts patient prognosis and facilitates the selection of personalized treatment strategies for HNSCC.

Jinhao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.